Misconceptions Surrounding Hepatocellular Carcinoma
Nayantara Orekondy, Sheila Eswaran – 2 January 2019
Endoscopic Sedation of the Patient With Cirrhosis
Jerome C. Edelson, Don C. Rockey – 2 January 2019
Extracellular Vesicles in Liver Diseases: Meeting Report from the International Liver Congress 2018
Jesus M. Banales, Ariel E. Feldstein, Hanna Sänger, Veronika Lukacs‐Kornek, Gyongyi Szabo, Miroslaw Kornek – 2 January 2019 – Extracellular vesicles (EVs) are small and heterogeneous membrane‐bound structures released by cells and found in all biological fluids. They are effective intercellular communicators, acting on a number of close and/or distant target cells. EV cargo may reflect the cell of origin as well as the specific stress that induces their formation and release.
Endoscopic Sedation of the Patient With Cirrhosis
Jerome C. Edelson, Don C. Rockey – 2 January 2019
PRO: Needle Exchange Programs Should Be Instituted to Reduce Hepatitis C Virus Transmission
Thomas G. Cotter, Matthew W. Stier, Andrew Aronsohn – 2 January 2019
Return to Alcohol Use After Liver Transplant: Patterns and Surveillance
Brian P. Lee, Norah A. Terrault – 2 January 2019
CON: Needle Exchange Programs Should Not Be Instituted to Reduce Hepatitis C Virus Transmission
Ken O’Riordan, Mohsen Khan, Andrew Mazulis – 2 January 2019
Increasing Awareness on Racial Disparities in Liver Transplantation for Hepatocellular Carcinoma in the United States
Catherine T. Frenette – 1 January 2019
Issue Information
1 January 2019
Development of Hepatic Steatosis After Chemotherapy for Non‐Hodgkin Lymphoma
Gil Ben‐Yakov, Hawwa Alao, John P. Haydek, Nancy Fryzek, Min Ho Cho, Mehdi Hemmati, Vikram Samala, Margaret Shovlin, Kieron Dunleavy, Wyndham Wilson, Elizabeth C. Jones, Yaron Rotman – 28 December 2018 – Nonalcoholic fatty liver disease is the most common liver disorder in the developed world. Although typically reflecting caloric overload, it can also be secondary to drug toxicity. We aimed to describe the incidence and risk factors for de novo steatosis during chemotherapy for non‐Hodgkin lymphoma (NHL).